Your browser doesn't support javascript.
loading
Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin.
Jiang, Kejun; Song, Xu; Yang, Liuqing; Li, Lin; Wan, Zhuoya; Sun, Xun; Gong, Tao; Lin, Qing; Zhang, Zhirong.
Afiliação
  • Jiang K; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China.
  • Song X; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China.
  • Yang L; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China.
  • Li L; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China.
  • Wan Z; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15260, United States.
  • Sun X; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China.
  • Gong T; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China.
  • Lin Q; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China. Electronic address: qinglin@scu.edu.cn.
  • Zhang Z; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, PR China. Electronic address: zrzzl@vip.sina.com.
J Control Release ; 271: 21-30, 2018 02 10.
Article em En | MEDLINE | ID: mdl-29277681

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Mama / Doxorrubicina / Fibronectinas / Antibióticos Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias da Mama / Doxorrubicina / Fibronectinas / Antibióticos Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article